Yay! .. read this article the other day ... now that we've had 3 in under 12 months I think we'd fall into this category?
The road to FDA clearance for medical devices may change radically in the next year.
Last summer, initial discussion began around implementing a pre-certification program for medical device companies, which would allow certain companies that the FDA has deemed responsible and safe in their development to build products without each new device undergoing the FDA clearance or approval process.
http://www.mobihealthnews.com/conte...orkshops-give-industry-and-agency-chance-talk
“This, our third 510(k) clearance in under 12 months for the SOZO® platform, follows our recent clearance for monitoring fluid levels in heart failure patients, achieving yet another important regulatory milestone in our journey of providing a new and improved model of care, across the patient care continuum.”
- Forums
- ASX - By Stock
- IPD
- Ann: US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment
Ann: US FDA 510(k) Clearance for Bilateral Lymphoedema Assessment, page-2
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IPD (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
-0.001(1.79%) |
Mkt cap ! $111.2M |
Open | High | Low | Value | Volume |
5.7¢ | 5.7¢ | 5.4¢ | $43.81K | 805.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 5.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.5¢ | 333033 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 150000 | 0.052 |
1 | 500000 | 0.051 |
5 | 190000 | 0.050 |
2 | 77732 | 0.049 |
1 | 27812 | 0.048 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 333033 | 2 |
0.056 | 1005 | 1 |
0.057 | 250000 | 1 |
0.058 | 29118 | 2 |
0.059 | 100000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
IPD (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online